O ptimizing growth and development from conception to childhood through good nutrition, a clean environment, and adequate holistic health care is essential for the improvement of health and economic development of populations. 1, 2 Throughout this critical period, growth, which is a continuous process, must be monitored routinely with the use of congruent screening tools and criteria. Focusing conceptually on only 1 specific phase or a single summary value (eg, late fetal growth or estimated fetal weight) has limited biologic basis and lessens the chances for timely and appropriate interventions.
Growth monitoring (GM) is an integral and undisputed component of evidence-based antenatal and newborn care worldwide, as it is for infants and children. However, to be effective, GM requires a comprehensive set of anthropometric standards that enable skeletal growth (eg, fetal head circumference or postnatal length) and fat-related markers (eg, fetal abdominal circumference or postnatal weight) to be assessed longitudinally so that judgments can be made about the appropriateness of growth patterns and deviations (eg, whether the fetus/newborn/infant is wasted, stunted, or overweight/obese). 3 These tools have been available to evaluate term infants'
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Two barriers thwart the implementation of the missing perinatal component of the GM strategy. First, unlike in most other fields of medicine, descriptive reference charts, rather than prescriptive standards, are used in obstetric and neonatal practice. Standards are preferable because they describe aspirational, biologic norms that are achieved by healthy populations and individuals throughout the world. References, on the other hand, describe the distribution of variables that are observed in unselected samples at a given time and place, often decades ago. 4 They provide information that is of limited value today for clinicians, parents, and families because the criteria used to select subjects and define their health were often ill-defined. This applies, for example, to the Hadlock charts of estimated fetal weight, which are presently used worldwide, evaluated in 109 fetuses from a hospital in Texas in the 1980s. 5 The second barrier is the large number and limited methodologic quality of the charts that are available to obstetricians and neonatologists. In a series of systematic reviews, we showed that there are (1) 29 published charts for estimating gestational age that use crown rump length, of which only 4 satisfied minimum quality criteria 6 ; (2) 83 published fetal size charts for monitoring growth by ultrasound scanning, of which only 12 used a reliable dating method 7 ; (3) 102 published charts of birthweight for gestational age, of which only 8 satisfied minimum quality criteria, 8 and (4) 61 published postnatal growth charts for preterm infants with considerable shortcomings in the quality of anthropometric evaluation, gestational age estimation, length of follow-up evaluation, and reportage of postnatal care, feeding regimes, and morbidities. In addition, the choice of a particular reference chart is too often based on clinicians' preferences or on the default chart offered in the ultrasound machine's software, which can lead to different references being used even within the same medical practice. Finally, there is considerable variability in the definition of intrauterine growth restriction (IUGR) with the use of combinations of ultrasound measures. Consequently, clinicians currently monitor fetuses and newborn infants at different levels of care and institutions with a wide range of charts. Variable cutoff points (3rd, 5th, 10th, 90th, 95th, or 97th percentiles) are used to define "normality," macrosomia, and IUGR. Often there is little appreciation of the underlying population or quality of the study that generated the chart being used. Consequently, fetuses can be classified as growth-restricted or overgrown in 1 part of a city or country and as healthy in another. For example, Salomon et al 9 showed that the proportion of fetuses who were classified as having a biparietal diameter below the 5th percentile at 20-24 weeks of gestation can range from 6.6e23.7% with the use of 3 different popular ultrasound reference charts. More confusing still is that, only 1 month after birth, infants are evaluated by pediatricians with the use of a single, prescriptive tool, the World Health Organization (WHO) Child Growth Standards, that was derived from healthy newborn infants from populations with few growth-restricting factors whose mothers followed breastfeeding recomendations. 10 This situation must result inevitably in diagnostic inaccuracies, confusion for parents, and inappropriate interventions.
In an era of evidence-based medicine, supporting an approach in which different tools and criteria are used depending on whether the babies are inside the womb, newly born, or aged 1 month is difficult to justify scientifically and to parents. The fact that the WHO Child Growth Standards have been adopted in >125 countries, including the United States, United Kingdom, and Norway, 11 demonstrates that standardization of care is feasible and acceptable across vastly different countries and medical systems.
The International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) Project has produced an integrated set of standards for gestational age estimation, 12 first-trimester fetal size, 12 fetal growth 13 (to be supported by fetal growth velocity and estimated fetal weight standards in 2016), newborn size for gestational age, 14 postnatal growth of preterm infants, 15 and, in 2016, infant development at 2 years old. 16 The percentiles of the INTERGROWTH-21st newborn standards are remarkably similar at term to those of the WHO Child Growth Standards (Figure 1) , which is not surprising because the 2 studies adopted the same conceptual, methodologic, and analytic approaches. This means that growth and development, for the first time, can be monitored with the same high-quality tools across the vital first 1000 days and up to the age of 5 years.
The INTERGROWTH-21st standards were developed from a prospective, population-based project that selected 8 urban areas across 5 continents. Most inhabitants were healthy, adequately nourished, and educated with minimal environmental constraints on growth. 17 Within each of these study sites, in a second sampling step, pregnant women at low risk of IUGR were recruited. 18 All of them had a reliable estimate of gestational age confirmed by ultrasound scanning. The same, specially adapted, ultrasound equipment was used at all sites to allow blinding of measurements. A novel quality-control strategy, which included centralized image storage, enabled the independent review of images and measurements. 19, 20 Newborn infants were measured with the same methods and quality control protocols as in the WHO Child Growth Standards Study 21 with a follow-up study of their growth, diet, morbidity, and cognitive development 16 until 2 years of age from which a functional classification of IUGR and macrosomia will be generated. Reassuringly, the growth and development at 1 year of age of term and preterm newborn infants closely match the WHO Child Growth Standards.
13,15
Although we have presented our curves with commonly used statistical cutoffs (eg, 3rd and 97th percentiles), as is the case for infant and child growth standards, 10 we presently are conducting analyses to identify which cutoff points best predict perinatal and postnatal outcomes 14 for incorporation in an evidence-based triage for global perinatal care.
It could be argued that the observed geographic and ethnic variations in fetal growth across populations preclude the use of international standards. These arguments are difficult to support, given the widespread use in medicine of universal definitions based on data that are 
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The 3rd, 50th, and 97th percentile curves for birthweight according to gestational age and sex (A, boys; B, girls) from the INTERGROWTH-21st Newborn Size Standards 14 (red lines) followed by the corresponding 3rd, 50th, and 97th percentile curves from the World Health Organization Child Growth Standards for term (40 weeks of gestation) newborn infants according to sex. GM of the fetus, neonate, and child up to 5 years old should be done in the same way. International standards are justified by the evidence that skeletal and linear growth in humans is similar from conception to childhood across geographic populations, when health, nutrition, and health care needs are met. These data demonstrate that only <4% of the total variability in growth and size during pregnancy, at birth, during infancy, and childhood can be attributed to differences between populations, as opposed to variability among individuals within the same population (Table) . 10, 22, 23 The alternative (ie, the use of local charts based on unselected samples) involves major clinical and public health risks. First, if fetuses and newborn infants are evaluated in such a manner, the rate of IUGR or small-for-gestational age <10th percentile, by definition, will be close to 10% in all populations, regardless of the local prevalence of malnutrition or morbidity, which is A and B, Crown rump length and fetal head circumference 3rd, 50th, and 97th percentiles for the total Fetal Growth Longitudinal Study population (solid line); the remaining sample after data from the sites in China, India, Kenya, and the UK were excluded one at a time. C, Birth length at 3rd, 50th, and 97th percentiles for the low-risk proportion of the total Newborn CrossSectional Study population (solid line), and the remaining sample after data from the sites in China, India, Kenya, and the UK were excluded one at a time. A detailed description of the studies and analytic strategy is available in the article by Villar et al. 22 Reproduced, with permission, from Villar J et al. 22 Villar. Monitoring human growth and development. Am J Obstet Gynecol 2015.
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Obstetrics Clinical Opinion epidemiologically implausible. For example, recently it was estimated that the prevalence of small-for-gestational age in low-to-middle income countries is at least 24% 24 and the prevalence of stunting in these countries ranges from 10e40%, 2 which is in keeping with the corresponding rates of stillbirth and neonatal, infant, and <5-year morbidity and mortality. 25 At the other end of the spectrum, whenever local unselected populations in developed regions are used as their own reference, overweight newborn infants are considered "normal" (ie, their early obesity is not diagnosed). This occurs because many countries and subpopulations, in the midst of the childhood obesity and diabetes mellitus epidemics, 26 have shifted their percentiles upwards to include bigger babies. For example, in England in 2011-2012 the rate of birthweight >90th percentile was 11% using local references but 19% using international standards. 27 Only by using a single set of international newborn size standards 14 can the 2 situations described earlier be avoided.
Another argument against the use of the international newborn size standards is the variability that is observed between the highest and lowest birthweights in the populations that are used for their construction. Clearly, some variability exists even in the healthy populations included in the INTERGROWTH-21st Project, but such a comparison is not relevant to the question of whether to use international growth standards. It was never suggested nor recommended that data from a single country should be used to evaluate another population or vice versa. The question is not how a single population of fetuses or newborn babies compares in length or weight with another population such as the United Kingdom's. The question, instead, is how each of these compares with the international standards that were constructed with all populations combined. Sensitivity analyses demonstrated that the exclusion of any of the populations in the WHO Child Growth Standards Study or INTERGROWTH-21st Project had negligible effect on the pooled values from all the study sites and that the percentiles were indistinguishable when superimposed (Figure 2 ). 22 Furthermore, recommending that growth charts should be ethnic/racialspecific, based on the concept that certain ethnic or racial groups have a genetic predisposition to small or large size at birth, has no scientific basis in nonisolated populations. First, ethnicity and race are social, not biologic, constructs. As a Nature Biotechnology 2005 editorial concluded: "Scientifically, race is a meaningless marker of anything. Pooling people in race silos is akin to zoologists grouping raccoons, tigers and okapis on the basis that they are all stripey." 28 These are not even well-defined terms: a systematic review identified 116 definitions of self-reported race or ethnicity in the medical literature. 29 Second, most populations have been subjected to marked genetic admixture, including the United States, 30 such that >6 million North Americans, who selfidentify as European, probably carry African ancestry. 31 Third, nearly 700 genetic variants have been implicated in adult height (compared with the few associated with skin pigmentation), but even these only explain one-fifth of the heritability of height. 32 The concept is also contradicted by the overwhelming literature that links physical growth in humans to socioeconomic, environmental, health, and nutrition conditions worldwide. 33 Hence, there is no scientific basis for the adaption of fetal or newborn growth charts based on the self-reported ethnicity of the mother, which is a procedure that makes even less practical sense when we consider the multiple permutations of mixedethnicity couples and the extent of present-day mass migration.
In summary, integrated monitoring of growth and development from pregnancy to school age is desirable, scientifically supported, and likely both to standardize and improve health care and referral patterns. Such integration can be achieved only through the use of international growth standards, especially in increasingly diverse mixed ancestry populations. These standards allow, for the first time, comparisons to be made across populations from conception onwards. They also greatly facilitate our ability to address concerns about fetal development and associated health problems in later life by producing standardized global data instead of the present paltry mishmash. However, the implementation of the standards requires giving consideration to the resource implications, which include the capacity of referral systems to manage the number and severity of identified cases (which depends on the cutoff points selected) and the prevalence of risk factors. Operating within a uniform system requires professional adaptation and coordination across levels of care. As never occurred when the large number of currently used fetal and neonatal charts were introduced, it will be important to monitor how the new standards are adopted and how deviations from optimal growth are interpreted. We are confident that, in time, the INTERGROWTH-21st standards will be incorporated into care and research 34, 35 just as the WHO Child Growth Standards are used currently by pediatricians worldwide.
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